Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma

被引:118
|
作者
Xu, Zhijie [1 ]
Peng, Bi [1 ]
Liang, Qiuju [2 ,3 ]
Chen, Xi [2 ,3 ]
Cai, Yuan [1 ]
Zeng, Shuangshuang [2 ,3 ]
Gao, Kewa [1 ]
Wang, Xiang [2 ,3 ]
Yi, Qiaoli [2 ,3 ]
Gong, Zhicheng [2 ,3 ]
Yan, Yuanliang [2 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
ferroptosis; immune cell infiltrate; lncRNA; hepatocellular carcinoma; survival analysis; EXPRESSION; SURVIVAL;
D O I
10.3389/fimmu.2021.719175
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ferroptosis is an iron-dependent cell death process that plays important regulatory roles in the occurrence and development of cancers, including hepatocellular carcinoma (HCC). Moreover, the molecular events surrounding aberrantly expressed long non-coding RNAs (lncRNAs) that drive HCC initiation and progression have attracted increasing attention. However, research on ferroptosis-related lncRNA prognostic signature in patients with HCC is still lacking. In this study, the association between differentially expressed lncRNAs and ferroptosis-related genes, in 374 HCC and 50 normal hepatic samples obtained from The Cancer Genome Atlas (TCGA), was evaluated using Pearson's test, thereby identifying 24 ferroptosis-related differentially expressed lncRNAs. The least absolute shrinkage and selection operator (LASSO) algorithm and Cox regression model were used to construct and validate a prognostic risk score model from both TCGA training dataset and GEO testing dataset (GSE40144). A nine-lncRNA-based signature (CTD-2033A16.3, CTD-2116N20.1, CTD-2510F5.4, DDX11-AS1, LINC00942, LINC01224, LINC01231, LINC01508, and ZFPM2-AS1) was identified as the ferroptosis-related prognostic model for HCC, independent of multiple clinicopathological parameters. In addition, the HCC patients were divided into high-risk and low-risk groups according to the nine-lncRNA prognostic signature. The gene set enrichment analysis enrichment analysis revealed that the lncRNA-based signature might regulate the HCC immune microenvironment by interfering with tumor necrosis factor alpha/nuclear factor kappa-B, interleukin 2/signal transducers and activators of transcription 5, and cytokine/cytokine receptor signaling pathways. The infiltrating immune cell subtypes, such as resting memory CD4(+) T cells, follicular helper T cells, regulatory T cells, and M0 macrophages, were all significantly different between the high-risk group and the low-risk group as indicated in Spearman's correlation analysis. Moreover, a substantial increase in the expression of B7H3 immune checkpoint molecule was found in the high-risk group. Our findings provided a promising insight into ferroptosis-related lncRNAs in HCC and a personalized prediction tool for prognosis and immune responses in patients.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma
    Qin, Yuan
    Zhang, Dai
    Zhang, Huan
    Hou, Lan
    Wang, Zhe
    Yang, Liu
    Zhang, Mingkun
    Zhao, Ge
    Yao, Qing
    Ling, Rui
    Zhang, Juliang
    [J]. CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [2] Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma
    Yuan Qin
    Dai Zhang
    Huan Zhang
    Lan Hou
    Zhe Wang
    Liu Yang
    Mingkun Zhang
    Ge Zhao
    Qing Yao
    Rui Ling
    Juliang Zhang
    [J]. Cancer Cell International, 22
  • [3] Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
    Chongkai Fang
    Silin Liu
    Kunliang Feng
    Chaoyuan Huang
    Ying Zhang
    Jinan Wang
    Hongtong Lin
    Junyan Wang
    Chong Zhong
    [J]. Scientific Reports, 12
  • [4] Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
    Fang, Chongkai
    Liu, Silin
    Feng, Kunliang
    Huang, Chaoyuan
    Zhang, Ying
    Wang, Jinan
    Lin, Hongtong
    Wang, Junyan
    Zhong, Chong
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [5] Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
    Huang, Anmin
    Li, Ting
    Xie, Xueting
    Xia, Jinglin
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [6] Construction of a ferroptosis-related lncRNA signature for predicting prognosis, immune response and drug sensitivity in cervical squamous cell carcinoma and endocervical adenocarcinoma
    Gu, Tingting
    Xu, Caihong
    Chen, Jing
    Wan, Bin
    Wang, Wei
    Shi, Jun
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2023, 44 (06) : 29 - 42
  • [7] A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma
    Lian, Jie
    Zhang, Chaoyu
    Lu, Haibo
    [J]. COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [8] Identification of m6A-and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma
    Xie, Hongjun
    Shi, Muqi
    Liu, Yifei
    Cheng, Changhong
    Song, Lining
    Ding, Zihan
    Jin, Huanzhi
    Cui, Xiaohong
    Wang, Yan
    Yao, Dengfu
    Wang, Peng
    Yao, Min
    Zhang, Haijian
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] Comprehensive Analysis of a Ferroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Landscape in Osteosarcoma
    Zhang, Yiming
    He, Rong
    Lei, Xuan
    Mao, Lianghao
    Yin, Zhengyu
    Zhong, Xinyu
    Cao, Wenbing
    Zheng, Qiping
    Li, Dapeng
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma
    Zhang, Ze
    Zhang, Wenwen
    Wang, Yafei
    Wan, Tao
    Hu, Bingyang
    Li, Chonghui
    Ge, Xinlan
    Lu, Shichun
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10